Modafinil (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Modafinil" in Italian language version.

Last modified: 16:09:43, 17 April 2026 (UTC)

Ref.Un. Ref.Website

Global rank Italian rank

3428doi.org

2^nd place

3^rd place

3328nih.gov

5^th place

6^th place

2015oadoi.org

612^th place

14^th place

77web.archive.org

1^st place

77archive.is

76^th place

11^th place

65archive.org

6^th place

2^nd place

33fda.gov

470^th place

624^th place

22bmj.com

1,341^st place

859^th place

22europa.eu

62^nd place

64^th place

11provigil.com

low place

11psychiatrist.com

low place

11worldcat.org

4^th place

18^th place

11unibo.it

3,746^th place

288^th place

11lww.com

2,576^th place

1,502^nd place

11psychiatryonline.org

4,883^rd place

3,820^th place

11nida

low place

11nytimes.com

7^th place

15^th place

archive.is (Global: 76^th place; Italian: 11^th place)

(EN) P. Jenner, B.-Y. Zeng, L.A. Smith, R.K.B. Pearce, B. Tel, L. Chancharme e G. Moachon, Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset (abstract), vol. 133, Springer-Verlag, luglio 2000, pp. 178-188, DOI:10.1007/s002210000370, ISSN 0014-4819 (WC · ACNP). URL consultato il 17 ottobre 2022 (archiviato dall'url originale l'11 gennaio 2013).
(EN) Menza MA, Kaufman KR e Castellanos A., Modafinil augmentation of antidepressant treatment in depression, in J Clin Psychiatry, vol. 61, n. 11, PubMed, 2000, pp. 378-381, PMID 10847314. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) DeBattista C, Lembke A, Solvason HB, Ghebremichael R e Poirier J., A prospective trial of modafinil as an adjunctive treatment of major depression (abstract), in J Clin Psychopharmacol, vol. 24, n. 1, 2004, pp. 87-90, DOI:10.1097/01.jcp.0000104910.75206.b9. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) J. R. MacDonald, PhD, J. D. Hill, MSc e M. A. Tarnopolsky, MD PhD, Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy (abstract), in Neurology, vol. 59, 20 agosto 2002, pp. 1876-1880, PMID 12499477. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 18 gennaio 2013).
(EN) Webster L, Andrews M e Stoddard G., Modafinil treatment of opioid-induced sedation (abstract), in Pain Med, vol. 4, n. 2, PubMed, giugno 2003, pp. 135-140, DOI:10.1046/j.1526-4637.2003.03014.x. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) Hurst DL e Lajara-Nanson W., Use of modafinil in cerebral palsy (abstract), in J Child Neurology, vol. 17, n. 3, marzo 2002, pp. 169-172, DOI:10.1177/088307380201700303, PMID 12026230. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) Nieves AV e Lang AE, Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil (abstract), in Clin. Neuropharmacol., vol. 25, n. 2, marzo 2002, pp. 111-114, DOI:10.1097/00002826-200203000-00010. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).

archive.org (Global: 6^th place; Italian: 2^nd place)

Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV, Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil, in Neurosci. Lett., vol. 241, n. 2-3, gennaio 1998, pp. 95-8, PMID 9507929.
Biederman J, Pliszka SR, Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents, in J. Pediatr., vol. 152, n. 3, marzo 2008, pp. 394-9, DOI:10.1016/j.jpeds.2007.07.052, PMID 18280848.
Baranski JV, Pigeau R, Dinich P, Jacobs I, Effects of modafinil on cognitive and meta-cognitive performance, in Hum Psychopharmacol, vol. 19, n. 5, 2004, pp. 323-32, DOI:10.1002/hup.596, PMID 15252824.
Randall DC, Shneerson JM, File SE, Cognitive effects of modafinil in student volunteers may depend on IQ, in Pharmacol. Biochem. Behav., vol. 82, n. 1, 2005, pp. 133-9, DOI:10.1016/j.pbb.2005.07.019, PMID 16140369.
Lindsay SE, Gudelsky GA, Heaton PC, Use of modafinil for the treatment of attention deficit/hyperactivity disorder, in Ann Pharmacother, vol. 40, n. 10, ottobre 2006, pp. 1829-33, DOI:10.1345/aph.1H024, PMID 16954326.

bmj.com (Global: 1,341^st place; Italian: 859^th place)

jnnp.bmj.com

Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, in J. Neurol. Neurosurg. Psychiatr., vol. 72, n. 2, febbraio 2002, pp. 179-83, PMC 1737733, PMID 11796766.
K W Rammohan, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, in Journal of Neurology Neurosurgery and Psychiatry, vol. 72, n. 2, 2002, pp. 179-183, DOI:10.1136/jnnp.72.2.179, PMID 11796766.

doi.org (Global: 2^nd place; Italian: 3^rd place)

dx.doi.org

Ishizuka T, Murakami M, Yamatodani A, Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats, in Eur. J. Pharmacol., vol. 578, n. 2-3, gennaio 2008, pp. 209-15, DOI:10.1016/j.ejphar.2007.09.009, PMID 17920581.
Biederman J, Pliszka SR, Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents, in J. Pediatr., vol. 152, n. 3, marzo 2008, pp. 394-9, DOI:10.1016/j.jpeds.2007.07.052, PMID 18280848.
Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ, Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness, in Ann Clin Psychiatry, vol. 19, n. 3, 2007, pp. 153-9, DOI:10.1080/10401230701464858, PMID 17729016.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 1, gennaio 2005, pp. 205-11, DOI:10.1038/sj.npp.1300600, PMID 15525998.
Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ, Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia, in Neuropsychopharmacology, vol. 29, n. 7, luglio 2004, pp. 1363-73, DOI:10.1038/sj.npp.1300457, PMID 15085092.
Eduardo Lopes, Danielle Pereira e Nilce Sanny Costa da Silva Behrens, Cataplexy as a side effect of modafinil in a patient without narcolepsy, in Sleep Science, vol. 7, n. 1, 2014-3, pp. 47-49, DOI:10.1016/j.slsci.2014.07.015. URL consultato il 21 marzo 2019.
{ Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ, Cognitive enhancing effects of modafinil in healthy volunteers, in Psychopharmacology (Berl.), vol. 165, n. 3, 2003, pp. 260-9, DOI:10.1007/s00213-002-1250-8, PMID 12417966.
Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE, Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?, in J Clin Psychopharmacol, vol. 25, n. 2, 2005, pp. 175-9, DOI:10.1097/01.jcp.0000155816.21467.25, PMID 15738750.
Baranski JV, Pigeau R, Dinich P, Jacobs I, Effects of modafinil on cognitive and meta-cognitive performance, in Hum Psychopharmacol, vol. 19, n. 5, 2004, pp. 323-32, DOI:10.1002/hup.596, PMID 15252824.
Müller U, Steffenhagen N, Regenthal R, Bublak P, Effects of modafinil on working memory processes in humans, in Psychopharmacology (Berl.), vol. 177, n. 1-2, 2004, pp. 161-9, DOI:10.1007/s00213-004-1926-3, PMID 15221200.
Randall DC, Shneerson JM, File SE, Cognitive effects of modafinil in student volunteers may depend on IQ, in Pharmacol. Biochem. Behav., vol. 82, n. 1, 2005, pp. 133-9, DOI:10.1016/j.pbb.2005.07.019, PMID 16140369.
(EN) P. Jenner, B.-Y. Zeng, L.A. Smith, R.K.B. Pearce, B. Tel, L. Chancharme e G. Moachon, Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset (abstract), vol. 133, Springer-Verlag, luglio 2000, pp. 178-188, DOI:10.1007/s002210000370, ISSN 0014-4819 (WC · ACNP). URL consultato il 17 ottobre 2022 (archiviato dall'url originale l'11 gennaio 2013).
(EN) Ira Jacobs e Douglas G. Bell, Effects of Acute Modafinil Ingestion on Exercise Time to Exhaustion, in Medicine & Science in Sports & Exercise, vol. 36, n. 6, 2004-06, p. 1078, DOI:10.1249/01.MSS.0000128146.12004.4F. URL consultato il 26 febbraio 2023.
K W Rammohan, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, in Journal of Neurology Neurosurgery and Psychiatry, vol. 72, n. 2, 2002, pp. 179-183, DOI:10.1136/jnnp.72.2.179, PMID 11796766.
Lindsay SE, Gudelsky GA, Heaton PC, Use of modafinil for the treatment of attention deficit/hyperactivity disorder, in Ann Pharmacother, vol. 40, n. 10, ottobre 2006, pp. 1829-33, DOI:10.1345/aph.1H024, PMID 16954326.
Glen L. Xiong, M.D., Eric J. Christopher, M.D., and Jason Goebel, M.D., Modafinil as an Alternative to Methylphenidate as Augmentation for Depression Treatment, in Psychosomatics, vol. 46, Academy of Psychosomatic Physician, 2005, pp. 578-579, DOI:10.1176/appi.psy.46.6.578, PMID 16288139.
«Case report: Modafinil 200 mg daily replacing Methylphenidate 5 mg b.i.d in 78 year old cardiac patient»
(EN) DeBattista C, Lembke A, Solvason HB, Ghebremichael R e Poirier J., A prospective trial of modafinil as an adjunctive treatment of major depression (abstract), in J Clin Psychopharmacol, vol. 24, n. 1, 2004, pp. 87-90, DOI:10.1097/01.jcp.0000104910.75206.b9. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) Webster L, Andrews M e Stoddard G., Modafinil treatment of opioid-induced sedation (abstract), in Pain Med, vol. 4, n. 2, PubMed, giugno 2003, pp. 135-140, DOI:10.1046/j.1526-4637.2003.03014.x. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) Hurst DL e Lajara-Nanson W., Use of modafinil in cerebral palsy (abstract), in J Child Neurology, vol. 17, n. 3, marzo 2002, pp. 169-172, DOI:10.1177/088307380201700303, PMID 12026230. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) Nieves AV e Lang AE, Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil (abstract), in Clin. Neuropharmacol., vol. 25, n. 2, marzo 2002, pp. 111-114, DOI:10.1097/00002826-200203000-00010. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson E, Foltin RW, Modafinil attenuates disruptions in cognitive performance during simulated night-shift work, in Neuropsychopharmacology, vol. 31, n. 7, luglio 2006, pp. 1526-36, DOI:10.1038/sj.npp.1300991, PMID 16395298.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 1, 2005, pp. 205-11, DOI:10.1038/sj.npp.1300600, PMID 15525998.
Umanoff DF, Trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 12, 2005, pp. 2298; author reply 2299–300, DOI:10.1038/sj.npp.1300866, PMID 16294193.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, Reply: Do Self-Reports Reliably Assess Abstinence in Cocaine-Dependent Patients?, in Neuropsychopharmacology, vol. 30, n. 12, 2005, pp. 2299-300, DOI:10.1038/sj.npp.1300867.
David Henderson, Modafinil-Associated Weight Loss in a Clozapine-Treated Schizoaffective Disorder Patient, in Annals of Clinical Psychiatry;, vol. 17, n. 2, aprile–giugno 2005, pp. 95-97, DOI:10.1080/10401230590932407.
Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR, Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment, in J Clin Psychopharmacol, vol. 26, n. 4, agosto 2006, pp. 373-8, DOI:10.1097/01.jcp.0000227700.263.75.39, PMID 16855454.
Makris AP, Rush CR, Frederich RC, Kelly TH, Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity, in Appetite, vol. 42, n. 2, aprile 2004, pp. 185-95, DOI:10.1016/j.appet.2003.11.003, PMID 15010183.
Bonaventure P, Letavic M, Dugovic C, et al, Histamine H3 receptor antagonists: from target identification to drug leads, in Biochem. Pharmacol., vol. 73, n. 8, aprile 2007, pp. 1084-96, DOI:10.1016/j.bcp.2006.10.031, PMID 17129577.

europa.eu (Global: 62^nd place; Italian: 64^th place)

eur-lex.europa.eu

eur-lex.europa.eu, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52021AT39686(02)&rid=5 Titolo mancante per url url (aiuto).
Riapertura del contezioso, su eur-lex.europa.eu.

fda.gov (Global: 470^th place; Italian: 624^th place)

U.S. Food and Drug Administration. Prescription Drug Marketing Act of 1987 (PDMA), PL 100-293. Link.
Psychopharmacologic Drugs Advisory Committee (transcript), su fda.gov, FDA, 23 marzo 2006.
Modafinil (CEP-1538) Tablets Supplemental NDA 20-717/S-019 ADHD Indication Briefing Document for Psychopharmacologic Drugs Advisory Committee Meeting (PDF), su fda.gov, FDA, 23 marzo 2006. URL consultato il 21 luglio 2007.

lww.com (Global: 2,576^th place; Italian: 1,502^nd place)

journals.lww.com

(EN) Ira Jacobs e Douglas G. Bell, Effects of Acute Modafinil Ingestion on Exercise Time to Exhaustion, in Medicine & Science in Sports & Exercise, vol. 36, n. 6, 2004-06, p. 1078, DOI:10.1249/01.MSS.0000128146.12004.4F. URL consultato il 26 febbraio 2023.

nida (Global: low place; Italian: low place)

National Institute on Drugs Abuse, Report of hearing in the Senate of United States in 2011 in 2019 (the last one the spokeswomen for NIDA was her director Dr. Nora Volokov, in NATIONAL INSTITUTE on DRUG ABUSE wed site at http://nida/govhttps://archives.drugabuse.gov/testimonies/2014/americas-addiction-to-opioids-heroin-prescription-drug-abuse.

nih.gov (Global: 5^th place; Italian: 6^th place)

ncbi.nlm.nih.gov

Ishizuka T, Murakami M, Yamatodani A, Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats, in Eur. J. Pharmacol., vol. 578, n. 2-3, gennaio 2008, pp. 209-15, DOI:10.1016/j.ejphar.2007.09.009, PMID 17920581.
Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV, Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil, in Neurosci. Lett., vol. 241, n. 2-3, gennaio 1998, pp. 95-8, PMID 9507929.
Biederman J, Pliszka SR, Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents, in J. Pediatr., vol. 152, n. 3, marzo 2008, pp. 394-9, DOI:10.1016/j.jpeds.2007.07.052, PMID 18280848.
Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ, Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness, in Ann Clin Psychiatry, vol. 19, n. 3, 2007, pp. 153-9, DOI:10.1080/10401230701464858, PMID 17729016.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 1, gennaio 2005, pp. 205-11, DOI:10.1038/sj.npp.1300600, PMID 15525998.
van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens IH, Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects, in Behav Pharmacol, vol. 17, n. 5-6, settembre 2006, pp. 453-62, PMID 16940766. URL consultato il 1º ottobre 2008 (archiviato dall'url originale il 26 febbraio 2012).
Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ, Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia, in Neuropsychopharmacology, vol. 29, n. 7, luglio 2004, pp. 1363-73, DOI:10.1038/sj.npp.1300457, PMID 15085092.
Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, in J. Neurol. Neurosurg. Psychiatr., vol. 72, n. 2, febbraio 2002, pp. 179-83, PMC 1737733, PMID 11796766.
Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ, Modafinil treatment for fatigue in HIV+ patients: a pilot study, in J Clin Psychiatry, vol. 65, n. 12, dicembre 2004, pp. 1688-95, PMID 15641875.
Eduardo Lopes, Danielle Pereira e Nilce Sanny Costa da Silva Behrens, Cataplexy as a side effect of modafinil in a patient without narcolepsy, in Sleep Science, vol. 7, n. 1, 2014-3, pp. 47-49, DOI:10.1016/j.slsci.2014.07.015. URL consultato il 21 marzo 2019.
{ Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ, Cognitive enhancing effects of modafinil in healthy volunteers, in Psychopharmacology (Berl.), vol. 165, n. 3, 2003, pp. 260-9, DOI:10.1007/s00213-002-1250-8, PMID 12417966.
Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE, Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?, in J Clin Psychopharmacol, vol. 25, n. 2, 2005, pp. 175-9, DOI:10.1097/01.jcp.0000155816.21467.25, PMID 15738750.
Baranski JV, Pigeau R, Dinich P, Jacobs I, Effects of modafinil on cognitive and meta-cognitive performance, in Hum Psychopharmacol, vol. 19, n. 5, 2004, pp. 323-32, DOI:10.1002/hup.596, PMID 15252824.
Müller U, Steffenhagen N, Regenthal R, Bublak P, Effects of modafinil on working memory processes in humans, in Psychopharmacology (Berl.), vol. 177, n. 1-2, 2004, pp. 161-9, DOI:10.1007/s00213-004-1926-3, PMID 15221200.
Randall DC, Shneerson JM, File SE, Cognitive effects of modafinil in student volunteers may depend on IQ, in Pharmacol. Biochem. Behav., vol. 82, n. 1, 2005, pp. 133-9, DOI:10.1016/j.pbb.2005.07.019, PMID 16140369.
K W Rammohan, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, in Journal of Neurology Neurosurgery and Psychiatry, vol. 72, n. 2, 2002, pp. 179-183, DOI:10.1136/jnnp.72.2.179, PMID 11796766.
Lindsay SE, Gudelsky GA, Heaton PC, Use of modafinil for the treatment of attention deficit/hyperactivity disorder, in Ann Pharmacother, vol. 40, n. 10, ottobre 2006, pp. 1829-33, DOI:10.1345/aph.1H024, PMID 16954326.
Glen L. Xiong, M.D., Eric J. Christopher, M.D., and Jason Goebel, M.D., Modafinil as an Alternative to Methylphenidate as Augmentation for Depression Treatment, in Psychosomatics, vol. 46, Academy of Psychosomatic Physician, 2005, pp. 578-579, DOI:10.1176/appi.psy.46.6.578, PMID 16288139.
«Case report: Modafinil 200 mg daily replacing Methylphenidate 5 mg b.i.d in 78 year old cardiac patient»
(EN) Menza MA, Kaufman KR e Castellanos A., Modafinil augmentation of antidepressant treatment in depression, in J Clin Psychiatry, vol. 61, n. 11, PubMed, 2000, pp. 378-381, PMID 10847314. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
(EN) J. R. MacDonald, PhD, J. D. Hill, MSc e M. A. Tarnopolsky, MD PhD, Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy (abstract), in Neurology, vol. 59, 20 agosto 2002, pp. 1876-1880, PMID 12499477. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 18 gennaio 2013).
(EN) Hurst DL e Lajara-Nanson W., Use of modafinil in cerebral palsy (abstract), in J Child Neurology, vol. 17, n. 3, marzo 2002, pp. 169-172, DOI:10.1177/088307380201700303, PMID 12026230. URL consultato il 17 ottobre 2022 (archiviato dall'url originale il 31 luglio 2013).
Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson E, Foltin RW, Modafinil attenuates disruptions in cognitive performance during simulated night-shift work, in Neuropsychopharmacology, vol. 31, n. 7, luglio 2006, pp. 1526-36, DOI:10.1038/sj.npp.1300991, PMID 16395298.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 1, 2005, pp. 205-11, DOI:10.1038/sj.npp.1300600, PMID 15525998.
Umanoff DF, Trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 12, 2005, pp. 2298; author reply 2299–300, DOI:10.1038/sj.npp.1300866, PMID 16294193.
Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR, Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment, in J Clin Psychopharmacol, vol. 26, n. 4, agosto 2006, pp. 373-8, DOI:10.1097/01.jcp.0000227700.263.75.39, PMID 16855454.
Thase ME, Fava M, DeBattista C, Arora S, Hughes RJ, Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study, in CNS Spectr, vol. 11, n. 2, febbraio 2006, pp. 93-102, PMID 16520686.
Makris AP, Rush CR, Frederich RC, Kelly TH, Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity, in Appetite, vol. 42, n. 2, aprile 2004, pp. 185-95, DOI:10.1016/j.appet.2003.11.003, PMID 15010183.
Bonaventure P, Letavic M, Dugovic C, et al, Histamine H3 receptor antagonists: from target identification to drug leads, in Biochem. Pharmacol., vol. 73, n. 8, aprile 2007, pp. 1084-96, DOI:10.1016/j.bcp.2006.10.031, PMID 17129577.

nytimes.com (Global: 7^th place; Italian: 15^th place)

nytimes.com, https://www.nytimes.com/2019/05/15/arts/design/met-museum-sackler-opioids.html Titolo mancante per url url (aiuto).

oadoi.org (Global: 612^th place; Italian: 14^th place)

Ishizuka T, Murakami M, Yamatodani A, Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats, in Eur. J. Pharmacol., vol. 578, n. 2-3, gennaio 2008, pp. 209-15, DOI:10.1016/j.ejphar.2007.09.009, PMID 17920581.
Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ, Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness, in Ann Clin Psychiatry, vol. 19, n. 3, 2007, pp. 153-9, DOI:10.1080/10401230701464858, PMID 17729016.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 1, gennaio 2005, pp. 205-11, DOI:10.1038/sj.npp.1300600, PMID 15525998.
Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ, Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia, in Neuropsychopharmacology, vol. 29, n. 7, luglio 2004, pp. 1363-73, DOI:10.1038/sj.npp.1300457, PMID 15085092.
{ Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ, Cognitive enhancing effects of modafinil in healthy volunteers, in Psychopharmacology (Berl.), vol. 165, n. 3, 2003, pp. 260-9, DOI:10.1007/s00213-002-1250-8, PMID 12417966.
Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE, Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?, in J Clin Psychopharmacol, vol. 25, n. 2, 2005, pp. 175-9, DOI:10.1097/01.jcp.0000155816.21467.25, PMID 15738750.
Müller U, Steffenhagen N, Regenthal R, Bublak P, Effects of modafinil on working memory processes in humans, in Psychopharmacology (Berl.), vol. 177, n. 1-2, 2004, pp. 161-9, DOI:10.1007/s00213-004-1926-3, PMID 15221200.
Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson E, Foltin RW, Modafinil attenuates disruptions in cognitive performance during simulated night-shift work, in Neuropsychopharmacology, vol. 31, n. 7, luglio 2006, pp. 1526-36, DOI:10.1038/sj.npp.1300991, PMID 16395298.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, A double-blind, placebo-controlled trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 1, 2005, pp. 205-11, DOI:10.1038/sj.npp.1300600, PMID 15525998.
Umanoff DF, Trial of modafinil for cocaine dependence, in Neuropsychopharmacology, vol. 30, n. 12, 2005, pp. 2298; author reply 2299–300, DOI:10.1038/sj.npp.1300866, PMID 16294193.
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, Reply: Do Self-Reports Reliably Assess Abstinence in Cocaine-Dependent Patients?, in Neuropsychopharmacology, vol. 30, n. 12, 2005, pp. 2299-300, DOI:10.1038/sj.npp.1300867.
David Henderson, Modafinil-Associated Weight Loss in a Clozapine-Treated Schizoaffective Disorder Patient, in Annals of Clinical Psychiatry;, vol. 17, n. 2, aprile–giugno 2005, pp. 95-97, DOI:10.1080/10401230590932407.
Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR, Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment, in J Clin Psychopharmacol, vol. 26, n. 4, agosto 2006, pp. 373-8, DOI:10.1097/01.jcp.0000227700.263.75.39, PMID 16855454.
Makris AP, Rush CR, Frederich RC, Kelly TH, Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity, in Appetite, vol. 42, n. 2, aprile 2004, pp. 185-95, DOI:10.1016/j.appet.2003.11.003, PMID 15010183.
Bonaventure P, Letavic M, Dugovic C, et al, Histamine H3 receptor antagonists: from target identification to drug leads, in Biochem. Pharmacol., vol. 73, n. 8, aprile 2007, pp. 1084-96, DOI:10.1016/j.bcp.2006.10.031, PMID 17129577.

provigil.com (Global: low place; Italian: low place)

"Provigil (Modafinil) Site." 12/24/1998 Provigil - Prescription Medicine Used to Improve Wakefulness, su provigil.com..

psychiatrist.com (Global: low place; Italian: low place)

article.psychiatrist.com

Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ, Modafinil treatment for fatigue in HIV+ patients: a pilot study, in J Clin Psychiatry, vol. 65, n. 12, dicembre 2004, pp. 1688-95, PMID 15641875.

psychiatryonline.org (Global: 4,883^rd place; Italian: 3,820^th place)

psy.psychiatryonline.org

Glen L. Xiong, M.D., Eric J. Christopher, M.D., and Jason Goebel, M.D., Modafinil as an Alternative to Methylphenidate as Augmentation for Depression Treatment, in Psychosomatics, vol. 46, Academy of Psychosomatic Physician, 2005, pp. 578-579, DOI:10.1176/appi.psy.46.6.578, PMID 16288139.
«Case report: Modafinil 200 mg daily replacing Methylphenidate 5 mg b.i.d in 78 year old cardiac patient»

unibo.it (Global: 3,746^th place; Italian: 288^th place)

acnpsearch.unibo.it

(EN) P. Jenner, B.-Y. Zeng, L.A. Smith, R.K.B. Pearce, B. Tel, L. Chancharme e G. Moachon, Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset (abstract), vol. 133, Springer-Verlag, luglio 2000, pp. 178-188, DOI:10.1007/s002210000370, ISSN 0014-4819 (WC · ACNP). URL consultato il 17 ottobre 2022 (archiviato dall'url originale l'11 gennaio 2013).

web.archive.org (Global: 1^st place; Italian: 1^st place)

Erman MK, Rosenberg R, For The U S Modafinil Shift Work Sleep Disorder Study Group. "Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life." Primary Care Companion to the Journal of Clinical Psychiatry 2007;9(3):188-94. Full Text (PDF) (archiviato dall'url originale il 15 luglio 2011).
van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens IH, Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects, in Behav Pharmacol, vol. 17, n. 5-6, settembre 2006, pp. 453-62, PMID 16940766. URL consultato il 1º ottobre 2008 (archiviato dall'url originale il 26 febbraio 2012).
News Release (Cephalon). "Cephalon, Inc. Plans to Acquire France's Group Lafon." WEST CHESTER, Pa., Dec 3, 2001 (PR Newswire) Link (archiviato dall'url originale il 10 febbraio 2007).
Efficacy and Safety of Modafinil Film-Coated Tablets in Children and Adolescents (PDF) (archiviato dall'url originale il 10 febbraio 2012).
11613_Provigil_PI_4pgr_lo4.indd (PDF) (archiviato dall'url originale il 1º maggio 2015).
"Doctors are finding it harder to deny 'Chemobrain'" (archiviato dall'url originale il 12 ottobre 2007)., The Virginian-Pilot, 2 ottobre 2007.
Modafinil Relieves Cognitive Chemotherapy Side Effects (archiviato dall'url originale l'11 ottobre 2008). Psychiatric News, Stephanie Whyche, 3 agosto 2007 Volume 42 Numero 15, p. 31

worldcat.org (Global: 4^th place; Italian: 18^th place)

(EN) P. Jenner, B.-Y. Zeng, L.A. Smith, R.K.B. Pearce, B. Tel, L. Chancharme e G. Moachon, Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset (abstract), vol. 133, Springer-Verlag, luglio 2000, pp. 178-188, DOI:10.1007/s002210000370, ISSN 0014-4819 (WC · ACNP). URL consultato il 17 ottobre 2022 (archiviato dall'url originale l'11 gennaio 2013).

Modafinil (Italian Wikipedia)

archive.is (Global: 76th place; Italian: 11th place)

archive.org (Global: 6th place; Italian: 2nd place)

bmj.com (Global: 1,341st place; Italian: 859th place)

jnnp.bmj.com

doi.org (Global: 2nd place; Italian: 3rd place)

dx.doi.org

europa.eu (Global: 62nd place; Italian: 64th place)

eur-lex.europa.eu

fda.gov (Global: 470th place; Italian: 624th place)

lww.com (Global: 2,576th place; Italian: 1,502nd place)

journals.lww.com

nida (Global: low place; Italian: low place)

nih.gov (Global: 5th place; Italian: 6th place)

ncbi.nlm.nih.gov

nytimes.com (Global: 7th place; Italian: 15th place)

oadoi.org (Global: 612th place; Italian: 14th place)

provigil.com (Global: low place; Italian: low place)

psychiatrist.com (Global: low place; Italian: low place)

article.psychiatrist.com

psychiatryonline.org (Global: 4,883rd place; Italian: 3,820th place)

psy.psychiatryonline.org

unibo.it (Global: 3,746th place; Italian: 288th place)

acnpsearch.unibo.it

web.archive.org (Global: 1st place; Italian: 1st place)

worldcat.org (Global: 4th place; Italian: 18th place)

archive.is (Global: 76^th place; Italian: 11^th place)

archive.org (Global: 6^th place; Italian: 2^nd place)

bmj.com (Global: 1,341^st place; Italian: 859^th place)

doi.org (Global: 2^nd place; Italian: 3^rd place)

europa.eu (Global: 62^nd place; Italian: 64^th place)

fda.gov (Global: 470^th place; Italian: 624^th place)

lww.com (Global: 2,576^th place; Italian: 1,502^nd place)

nih.gov (Global: 5^th place; Italian: 6^th place)

nytimes.com (Global: 7^th place; Italian: 15^th place)

oadoi.org (Global: 612^th place; Italian: 14^th place)

psychiatryonline.org (Global: 4,883^rd place; Italian: 3,820^th place)

unibo.it (Global: 3,746^th place; Italian: 288^th place)

web.archive.org (Global: 1^st place; Italian: 1^st place)

worldcat.org (Global: 4^th place; Italian: 18^th place)